HomeCompareIOFB vs MRK

IOFB vs MRK: Dividend Comparison 2026

IOFB yields 50.07% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IOFB wins by $359.3K in total portfolio value
10 years
IOFB
IOFB
● Live price
50.07%
Share price
$42.99
Annual div
$21.53
5Y div CAGR
0.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$417.0K
Annual income
$87,332.70
Full IOFB calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — IOFB vs MRK

📍 IOFB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIOFBMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IOFB + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IOFB pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IOFB
Annual income on $10K today (after 15% tax)
$4,256.13/yr
After 10yr DRIP, annual income (after tax)
$74,232.80/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, IOFB beats the other by $65,636.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IOFB + MRK for your $10,000?

IOFB: 50%MRK: 50%
100% MRK50/50100% IOFB
Portfolio after 10yr
$237.4K
Annual income
$48,723.24/yr
Blended yield
20.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IOFB
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IOFB buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIOFBMRK
Forward yield50.07%2.81%
Annual dividend / share$21.53$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.4%32.7%
Portfolio after 10y$417.0K$57.7K
Annual income after 10y$87,332.70$10,113.78
Total dividends collected$335.0K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IOFB vs MRK ($10,000, DRIP)

YearIOFB PortfolioIOFB Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,727$5,027.24$11,213$373.04+$4.5KIOFB
2$24,247$7,418.77$12,667$512.06+$11.6KIOFB
3$36,676$10,732.13$14,439$708.14+$22.2KIOFB
4$54,476$15,232.30$16,640$988.16+$37.8KIOFB
5$79,519$21,229.24$19,432$1,394.07+$60.1KIOFB
6$114,162$29,076.87$23,057$1,992.90+$91.1KIOFB
7$161,323$39,169.64$27,889$2,894.79+$133.4KIOFB
8$224,552$51,936.72$34,518$4,286.29+$190.0KIOFB
9$308,104$67,833.77$43,912$6,494.35+$264.2KIOFB
10$417,004$87,332.70$57,714$10,113.78+$359.3KIOFB

IOFB vs MRK: Complete Analysis 2026

IOFBStock

As of June 9, 2022, Iowa First Bancshares Corp. was acquired by MidWestOne Financial Group, Inc.. Iowa First Bancshares Corp. operates as the bank holding company for First National Bank of Muscatine and First National Bank in Fairfield that provide various banking products and services for individuals, businesses, and governmental organizations in Iowa. It offers checking, savings, money market, and time deposit accounts; and commercial and industrial, commercial real estate owner and non-owner occupied, agriculture, residential real estate, and consumer and other loans. The company also provides safe deposit, funds transmitting, trust, debit and credit card, Internet banking, automated teller machine, and other banking services. It operates through 4 locations in Muscatine and 2 locations in Fairfield, Iowa. The company was founded in 1870 and is headquartered in Muscatine, Iowa.

Full IOFB Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IOFB vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IOFB vs SCHDIOFB vs JEPIIOFB vs OIOFB vs KOIOFB vs MAINIOFB vs JNJIOFB vs ABBVIOFB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.